BD and CSMLS Announce Strategic Partnership Focusing on Education of Best Practice and Improving Patient Care

Sep 28, 2017

Mississauga, Ontario and Hamilton, Ontario - September 28, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company and the Canadian Society for Medical Laboratory Science (CSMLS) today announced a strategic collaboration focusing on education of best practice and current clinical standards for Canadian Medical Laboratory Technologists (MLTs) and Medical Laboratory Assistants (MLAs).

Under the terms of the agreement, CSMLS will create a series of new educational products, including live events, webinars and digital content that will be accessible to CSMLS members and BD customers.

“This collaboration brings the best of two organizations together, with a strong focus on improving patient care,” said Jamie Gallagher, country leader for BD - Canada’s Preanalytical Systems (PAS) business. “We are committed to providing ongoing education that focuses on quality outcomes and providing access to content from across Canada. We look forward to working alongside CSMLS to highlight the important work their members and our customers do and how it impacts the lives of patients every day.”

BD and CSMLS also announced the BD-sponsored CSMLS Awards (which replaces the previous Clinical Laboratory Management Association Awards). The BD Young Leaders Scholarship will provide funding for continuing education and professional development for a medical laboratory professional who is new to the field, and demonstrates leadership ability and commitment to continuous learning and development. The BD Quality Assurance Project Reward will provide a grant to an accredited clinical laboratory that can demonstrate positive results for a quality assurance or research project on the theme of “Improving the patient experience through organizational collaboration.” Both awards will be introduced in 2018 with details available on the CSMLS website: https://csmls.org/

“CSMLS is enthusiastic to be working in collaboration with BD,” said Michael Grant, director of marketing & communication for CSMLS. “Through this relationship, we hope to leverage the expertise and networks of both teams to provide relevant and important educational content to the laboratory community. We hope to explore the use of various digital formats which will allow us to provide cost-effective learning solutions that meet the needs of laboratory professionals’ busy lives. Together, BD and CSMLS will be seen as an innovative, go-to resource for content and that idea really excites us.”

About CSMLS
The Canadian Society for Medical Laboratory Science (CSMLS) is the national certifying body for medical laboratory technologists and medical laboratory assistants, and the national professional society for Canada's medical laboratory professionals. We are a not-for-profit organization that is funded entirely by membership dues and revenues from goods and services. We do not receive operational funding from governments or other organizations. Our members practice in hospital laboratories, private medical laboratories, public health laboratories, government laboratories, research and educational institutions. Incorporated in 1937 as the Canadian Society of Laboratory Technologists, the society has over 14,500 members in Canada and in countries around the world. For more information on CSMLS, please visit csmls.org.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.

For more information on BD, please visit bd.com.

Nadia Santoli


Email Nadia

Back to News Releases